DF13BYZLow Dose Rate (LDR) Brachytherapy of Pancreas using Other Isotope
- Billable / Specific Code
DF13BYZ is a billable ICD-10-PCS procedure code for Low Dose Rate (LDR) Brachytherapy of Pancreas using Other Isotope. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026).
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | D | Radiation Therapy |
| 2 | Body System | F | Hepatobiliary System and Pancreas |
| 3 | Modality | 1 | Brachytherapy |
| 4 | TreatmentSite | 3 | Pancreas |
| 5 | ModalityQualifier | B | Low Dose Rate (LDR) |
| 6 | Isotope | Y | Other Isotope |
| 7 | Qualifier | Z | None |
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for DF13BYZ under the General Equivalence Mappings.
Code History
- DF13B6Z — LDR Brachytherapy of Pancreas using Cesium 131
Similar Procedure Codes
Questions About DF13BYZ
Is DF13BYZ a billable code?
Yes. DF13BYZ is a complete seven-character ICD-10-PCS code, specific enough to report Low Dose Rate (LDR) Brachytherapy of Pancreas using Other Isotope on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in DF13BYZ mean?
DF13BYZ breaks down character by character: the 1st character D is the Section (Radiation Therapy); the 2nd character F is the Body System (Hepatobiliary System and Pancreas); the 3rd character 1 is the Modality (Brachytherapy); the 4th character 3 is the TreatmentSite (Pancreas); the 5th character B is the ModalityQualifier (Low Dose Rate (LDR)); the 6th character Y is the Isotope (Other Isotope); the 7th character Z is the Qualifier (None).
What is the ICD-9-PCS equivalent of DF13BYZ?
Under the General Equivalence Mappings, Low Dose Rate (LDR) Brachytherapy of Pancreas using Other Isotope crosswalks to ICD-9-PCS 92.23. The mapping is approximate, so confirm it fits the documentation.
